Rothschild Investment LLC Agios Pharmaceuticals, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 55 shares of AGIO stock, worth $3,248. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55
Previous 20
175.0%
Holding current value
$3,248
Previous $862,000
183.53%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AGIO
# of Institutions
227Shares Held
55.6MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$334 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$325 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$287 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$229 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$164 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $3.24B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...